These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38848043)

  • 1. Inhibition of Aberrantly Overexpressed Polo-like Kinase 4 Is a Potential Effective Treatment for DNA Damage Repair-Deficient Uterine Leiomyosarcoma.
    Lee HHY; Chow KL; Wong HS; Chong TY; Wong AST; Cheng GHW; Ko JMK; Siu HC; Yeung MCF; Huen MSY; Tse KY; Bray MR; Mak TW; Leung SY; Ip PPC
    Clin Cancer Res; 2024 Sep; 30(17):3904-3918. PubMed ID: 38848043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Polo-like kinase 4 induces mitotic defects and DNA damage in diffuse large B-cell lymphoma.
    Zhao Y; Yang J; Liu J; Cai Y; Han Y; Hu S; Ren S; Zhou X; Wang X
    Cell Death Dis; 2021 Jun; 12(7):640. PubMed ID: 34162828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant Activation of Cell-Cycle-Related Kinases and the Potential Therapeutic Impact of PLK1 or CHEK1 Inhibition in Uterine Leiomyosarcoma.
    Yoshida K; Yokoi A; Yamamoto T; Hayashi Y; Nakayama J; Yokoi T; Yoshida H; Kato T; Kajiyama H; Yamamoto Y
    Clin Cancer Res; 2022 May; 28(10):2147-2159. PubMed ID: 35302600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper ions are novel therapeutic agents for uterine leiomyosarcoma.
    Kakuda M; Matsuzaki S; Ueda Y; Shiomi M; Matsuzaki S; Kimura T; Fujita M; Egawa-Takata T; Kobayashi E; Serada S; Yoshino K; Naka T; Kimura T
    Am J Obstet Gynecol; 2020 Jan; 222(1):64.e1-64.e16. PubMed ID: 31351063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD70 antibody-drug conjugate as a potential therapeutic agent for uterine leiomyosarcoma.
    Nakae R; Matsuzaki S; Serada S; Matsuo K; Shiomi M; Sato K; Nagase Y; Matsuzaki S; Nakagawa S; Hiramatsu K; Okazawa A; Kimura T; Egawa-Takata T; Kobayashi E; Ueda Y; Yoshino K; Naka T; Kimura T
    Am J Obstet Gynecol; 2021 Feb; 224(2):197.e1-197.e23. PubMed ID: 32822640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin induces cross-regulation between autophagy and apoptosis in uterine leiomyosarcoma cells.
    Li B; Takeda T; Tsuiji K; Wong TF; Tadakawa M; Kondo A; Nagase S; Yaegashi N
    Int J Gynecol Cancer; 2013 Jun; 23(5):803-8. PubMed ID: 23532091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of the novel polo-like kinase 4 inhibitor CFI-400945 in pancreatic cancer patient-derived xenografts.
    Lohse I; Mason J; Cao PM; Pintilie M; Bray M; Hedley DW
    Oncotarget; 2017 Jan; 8(2):3064-3071. PubMed ID: 27902970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyper-Dependence on NHEJ Enables Synergy between DNA-PK Inhibitors and Low-Dose Doxorubicin in Leiomyosarcoma.
    Marino-Enriquez A; Novotny JP; Gulhan DC; Klooster I; Tran AV; Kasbo M; Lundberg MZ; Ou WB; Tao DL; Pilco-Janeta DF; Mao VY; Zenke FT; Leeper BA; Gokhale PC; Cowley GS; Baker LH; Ballman KV; Root DE; Albers J; Park PJ; George S; Fletcher JA
    Clin Cancer Res; 2023 Dec; 29(24):5128-5139. PubMed ID: 37773632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Co-targeting of WEE1 and ATM Downregulates PD-L1 Expression in Pancreatic Cancer.
    Jin MH; Nam AR; Park JE; Bang JH; Bang YJ; Oh DY
    Cancer Res Treat; 2020 Jan; 52(1):149-166. PubMed ID: 31291716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer Activity of the Combination of Cabozantinib and Temozolomide in Uterine Sarcoma.
    Noh JJ; Cho YJ; Ryu JY; Choi JJ; Hwang JR; Choi JY; Lee JW
    Clin Cancer Res; 2022 Sep; 28(17):3850-3861. PubMed ID: 35727598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dual PI3K/mTOR inhibitor NVP-BEZ235 is a potent inhibitor of ATM- and DNA-PKCs-mediated DNA damage responses.
    Mukherjee B; Tomimatsu N; Amancherla K; Camacho CV; Pichamoorthy N; Burma S
    Neoplasia; 2012 Jan; 14(1):34-43. PubMed ID: 22355272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End Joining.
    Zhou Q; Howard ME; Tu X; Zhu Q; Denbeigh JM; Remmes NB; Herman MG; Beltran CJ; Yuan J; Greipp PT; Boughey JC; Wang L; Johnson N; Goetz MP; Sarkaria JN; Lou Z; Mutter RW
    Cancer Res; 2021 Jun; 81(12):3333-3346. PubMed ID: 33597272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers.
    Kawakami M; Mustachio LM; Zheng L; Chen Y; Rodriguez-Canales J; Mino B; Kurie JM; Roszik J; Villalobos PA; Thu KL; Silvester J; Cescon DW; Wistuba II; Mak TW; Liu X; Dmitrovsky E
    Proc Natl Acad Sci U S A; 2018 Feb; 115(8):1913-1918. PubMed ID: 29434041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Hedgehog Pathway Inhibitors as a Therapeutic Option for Uterine Leiomyosarcoma Using the Xenograft Model.
    Garcia N; Ulin M; Ali M; Al-Hendy A; Carvalho KC; Yang Q
    Reprod Sci; 2022 Mar; 29(3):781-790. PubMed ID: 34642915
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Seligson ND; Kautto EA; Passen EN; Stets C; Toland AE; Millis SZ; Meyer CF; Hays JL; Chen JL
    Oncologist; 2019 Jul; 24(7):973-979. PubMed ID: 30541756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma.
    Babichev Y; Kabaroff L; Datti A; Uehling D; Isaac M; Al-Awar R; Prakesch M; Sun RX; Boutros PC; Venier R; Dickson BC; Gladdy RA
    J Transl Med; 2016 Mar; 14():67. PubMed ID: 26952093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma.
    Harold J; Bellone S; Manavella DD; Mutlu L; McNamara B; Hartwich TMP; Zipponi M; Yang-Hartwich Y; Demirkiran C; Verzosa MS; Choi J; Dong W; Buza N; Hui P; Altwerger G; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Santin AD
    Gynecol Oncol; 2023 Jan; 168():157-165. PubMed ID: 36442427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A small-molecule inhibitor targeting the mitotic spindle checkpoint impairs the growth of uterine leiomyosarcoma.
    Shan W; Akinfenwa PY; Savannah KB; Kolomeyevskaya N; Laucirica R; Thomas DG; Odunsi K; Creighton CJ; Lev DC; Anderson ML
    Clin Cancer Res; 2012 Jun; 18(12):3352-65. PubMed ID: 22535157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nutrient mixture reduced tumor growth of SK-UT-1 human leiomyosarcoma cells in vivo and in vitro by inhibiting MMPs and inducing apoptosis.
    Roomi MW; Bhanap B; Niedzwiecki A; Rath M
    Exp Oncol; 2021 Sep; 43(3):209-216. PubMed ID: 34591419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying and targeting cancer stem cells in leiomyosarcoma: prognostic impact and role to overcome secondary resistance to PI3K/mTOR inhibition.
    Fourneaux B; Bourdon A; Dadone B; Lucchesi C; Daigle SR; Richard E; Laroche-Clary A; Le Loarer F; Italiano A
    J Hematol Oncol; 2019 Jan; 12(1):11. PubMed ID: 30683135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.